Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) EBIT: 2013-2018

Historic EBIT for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to -$2.8 million.

  • Armata Pharmaceuticals' EBIT fell 18.14% to -$2.8 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$17.2 million, marking a year-over-year decrease of 6.34%. This contributed to the annual value of -$42.4 million for FY2024, which is 3.78% down from last year.
  • As of Q4 2018, Armata Pharmaceuticals' EBIT stood at -$2.8 million, which was down 15.03% from -$2.4 million recorded in Q3 2018.
  • Armata Pharmaceuticals' EBIT's 5-year high stood at -$746,000 during Q3 2017, with a 5-year trough of -$11.9 million in Q4 2016.
  • Moreover, its 3-year median value for EBIT was -$3.4 million (2016), whereas its average is -$4.9 million.
  • Per our database at Business Quant, Armata Pharmaceuticals' EBIT crashed by 303.54% in 2016 and then skyrocketed by 80.07% in 2017.
  • Over the past 5 years, Armata Pharmaceuticals' EBIT (Quarterly) stood at -$2.6 million in 2014, then decreased by 13.21% to -$2.9 million in 2015, then plummeted by 303.54% to -$11.9 million in 2016, then skyrocketed by 80.07% to -$2.4 million in 2017, then declined by 18.14% to -$2.8 million in 2018.
  • Its EBIT stands at -$2.8 million for Q4 2018, versus -$2.4 million for Q3 2018 and -$9.6 million for Q2 2018.